Rotenone Model of Parkinson Disease

Chronic infusion of rotenone (Rot) to Lewis rats reproduces many features of Parkinson disease. Rot (3 mg/kg/day) was infused subcutaneously to male Lewis rats for 6 days using Alzet minipumps. Control rats received the vehicle only. Presence of 0.1% bovine serum albumin during the isolation procedure completely removed rotenone bound to the mitochondria. Therefore all functional changes observed were aftereffects of rotenone toxicity in vivo. In Rot rat brain mitochondria (Rot-RBM) there was a 30-40% inhibition of respiration in State 3 and State 3U with Complex I (Co-I) substrates and succinate. Rot did not affect the State 4Δψ of RBM and rat liver mitochondria (RLM). However, Rot-RBM required two times less Ca2+ to initiate permeability transition (mPT). There was a 2-fold increase in \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\mathrm{O}_{2}^{{\bar{{\cdot}}}}\) \end{document} or H2O2 generation in Rot-RBM oxidizing glutamate. Rot infusion affected RLM little. Our results show that in RBM, the major site of reactive oxygen species generation with glutamate or succinate is Co-I. We also found that Co-II generates substantial amounts of reactive oxygen species that increased 2-fold in the Rot-RBM. Our data suggest that the primary mechanism of the Rot toxic effect on RBM consists in a significant increase of \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\mathrm{O}_{2}^{{\bar{{\cdot}}}}\) \end{document} generation that causes damage to Co-I and Co-II, presumably at the level of 4Fe-4S clusters. Decreased respiratory activity diminishes resistance of RBM to Ca2+ and thus increases probability of mPT and apoptotic cell death. We suggest that the damage to Co-I and Co-II shifts \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\mathrm{O}_{2}^{{\bar{{\cdot}}}}\) \end{document} generation from the CoQ10 sites to more proximal sites, such as flavines, and makes it independent of the RBM functional state.

[1]  D. Butterfield,et al.  Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia , 2005, Journal of the Neurological Sciences.

[2]  F. H. van der Westhuizen,et al.  Inhibition of complex I of the electron transport chain causes O2-. -mediated mitochondrial outgrowth. , 2005, American journal of physiology. Cell physiology.

[3]  I. Reynolds,et al.  Ca2+‐induced permeabilization promotes free radical release from rat brain mitochondria with partially inhibited complex I , 2005, Journal of neurochemistry.

[4]  Ken-ichi Yoshida,et al.  A Possible Site of Superoxide Generation in the Complex I Segment of Rat Heart Mitochondria , 2005, Journal of bioenergetics and biomembranes.

[5]  Andreas Schober,et al.  Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP , 2004, Cell and Tissue Research.

[6]  Vladimir N. Uversky,et al.  Neurotoxicant-induced animal models of Parkinson’s disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration , 2004, Cell and Tissue Research.

[7]  Werner J. Schmidt,et al.  Chronic administration of rotenone increases levels of nitric oxide and lipid peroxidation products in rat brain , 2004, Experimental Neurology.

[8]  A. Panov,et al.  Quantitative evaluation of the effects of mitochondrial permeability transition pore modifiers on accumulation of calcium phosphate: comparison of rat liver and brain mitochondria. , 2004, Archives of biochemistry and biophysics.

[9]  Nicolas Lapointe,et al.  Rotenone induces non‐specific central nervous system and systemic toxicity , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  G. Cecchini,et al.  Function and structure of complex II of the respiratory chain. , 2003, Annual review of biochemistry.

[11]  Todd B. Sherer,et al.  Mechanism of Toxicity in Rotenone Models of Parkinson's Disease , 2003, The Journal of Neuroscience.

[12]  A. Makrigiannakis,et al.  Endometrial Pinopodes and Uterine Receptivity , 2003, Annals of the New York Academy of Sciences.

[13]  D. Tweed,et al.  Adaptations and Deficits in the Vestibulo‐Ocular Reflex after Peripheral Ocular Motor Palsies , 2003, Annals of the New York Academy of Sciences.

[14]  D. Nicholls,et al.  The Relationship between Free and Total Calcium Concentrations in the Matrix of Liver and Brain Mitochondria* , 2003, Journal of Biological Chemistry.

[15]  Jean Féger,et al.  Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats , 2003, Journal of neurochemistry.

[16]  Todd B. Sherer,et al.  Subcutaneous Rotenone Exposure Causes Highly Selective Dopaminergic Degeneration and α-Synuclein Aggregation , 2003, Experimental Neurology.

[17]  A. Echaniz-Laguna,et al.  Mitochondrial respiratory chain function in skeletal muscle of ALS patients , 2002, Annals of neurology.

[18]  F. Forastiere,et al.  Evaluation of risk of Parkinson's disease in a cohort of licensed pesticide users , 2002, Neurological Sciences.

[19]  James R. Burke,et al.  Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines , 2002, Nature Neuroscience.

[20]  R. Mason,et al.  Noninvasive diagnostic tool for inflammation-induced oxidative stress using electron spin resonance spectroscopy and an extracellular cyclic hydroxylamine. , 2002, Archives of biochemistry and biophysics.

[21]  T. Sherer,et al.  Animal models of Parkinson's disease. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[22]  T. Sherer,et al.  Complex I and Parkinson's Disease , 2001, IUBMB life.

[23]  S. Khuder,et al.  Environmental risk factors and Parkinson's disease: a metaanalysis. , 2001, Environmental research.

[24]  C. Palmeira,et al.  Brain and liver mitochondria isolated from diabeticGoto‐Kakizaki rats show different susceptibility to induced oxidative stress , 2001, Diabetes/metabolism research and reviews.

[25]  M. Beal,et al.  Experimental models of Parkinson's disease , 2001, Nature Reviews Neuroscience.

[26]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[27]  J. Klaunig,et al.  Role of the mitochondrial membrane permeability transition (MPT) in rotenone-induced apoptosis in liver cells. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[28]  Françoise Condé,et al.  Replicating Huntington's disease phenotype in experimental animals , 1999, Progress in Neurobiology.

[29]  I. Reynolds Mitochondrial Membrane Potential and the Permeability Transition in Excitotoxicity , 1999, Annals of the New York Academy of Sciences.

[30]  S. Chakraborti,et al.  Oxidant, mitochondria and calcium: an overview. , 1999, Cellular signalling.

[31]  M. Beal,et al.  Mitochondrial dysfunction in neurodegenerative diseases. , 1998, Biochimica et biophysica acta.

[32]  C. Fall,et al.  Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. , 1997, Biochimica et biophysica acta.

[33]  H. Nishino,et al.  Systemic, but not intraparenchymal, administration of 3-nitropropionic acid mimics the neuropathology of Huntington's disease: a speculative explanation , 1997, Neuroscience Research.

[34]  A. Panov,et al.  Mg2+ control of respiration in isolated rat liver mitochondria. , 1996, Biochemistry.

[35]  M. Beal Mitochondria, free radicals, and neurodegeneration , 1996, Current Opinion in Neurobiology.

[36]  F. Sharp,et al.  MK-801 reduces uptake and stimulates efflux of excitatory amino acids via membrane depolarization. , 1996, The American journal of physiology.

[37]  J. Drapier,et al.  Modulation of Iron Regulatory Protein Functions , 1996, The Journal of Biological Chemistry.

[38]  J. Greene,et al.  Exacerbation of NMDA, AMPA, and l‐Glutamate Excitotoxicity by the Succinate Dehydrogenase Inhibitor Malonate , 1995, Journal of neurochemistry.

[39]  V. Massey Activation of molecular oxygen by flavins and flavoproteins. , 1994, The Journal of biological chemistry.

[40]  M. Crompton,et al.  An ADP-sensitive cyclosporin-A-binding protein in rat liver mitochondria. , 1994, European journal of biochemistry.

[41]  D. Flint,et al.  The inactivation of Fe-S cluster containing hydro-lyases by superoxide. , 1993, The Journal of biological chemistry.

[42]  D. Higgins,et al.  Quantitative Autoradiography of Dihydrorotenone Binding to Complex I of the Electron Transport Chain , 1992, Journal of neurochemistry.

[43]  N. Sims Rapid Isolation of Metabolically Active Mitochondria from Rat Brain and Subregions Using Percoll Density Gradient Centrifugation , 1990, Journal of neurochemistry.

[44]  G. Radda,et al.  Kinetic control of mitochondrial ATP synthesis. , 1986, Biochemistry.

[45]  T. Ohnishi,et al.  An analysis of some thermodynamic properties of iron-sulphur centres in site I of mitochondria. , 1980, The Biochemical journal.

[46]  E. Cadenas,et al.  Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. , 1977, Archives of biochemistry and biophysics.

[47]  P. Brookes,et al.  Mitochondrial H(+) leak and ROS generation: an odd couple. , 2005, Free radical biology & medicine.

[48]  F. Bricaire,et al.  Neurodegenerative diseases and oxidative stress. , 2004, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[49]  P. Jenner,et al.  Oxidative stress in Parkinson's disease , 2003, Annals of neurology.

[50]  I. Fridovich,et al.  Superoxide radical and superoxide dismutases. , 1995, Annual review of biochemistry.

[51]  L. Ernster,et al.  [87] Energy-coupling in nonphosphorylating submitochondrial particles , 1967 .